CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells

Open access

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a dominant cause of chronic liver disease, but the exact mechanism of progression from simple steatosis to nonalcoholic steatohepatitis (NASH) remains unknown. Here, we investigated the role of exosomes in NAFLD progression. Exosomes were isolated from a human hepatoma cell line treated with palmitic acid (PA) and their miRNA profiles examined by microarray. The human hepatic stellate cell (HSC) line (LX-2) was then treated with exosome isolated from hepatocytes. Compared with controls, PA-treated hepatocytes displayed significantly increased CD36 and exosome production. The microarray analysis showed there to be distinctive miRNA expression patterns between exosomes from vehicle- and PA-treated hepatocytes. When LX-2 cells were cultured with exosomes from PA-treated hepatocytes, the expression of genes related to the development of fibrosis were significantly amplified compared to those treated with exosomes from vehicle-treated hepatocytes. In conclusion, PA treatment enhanced the production of exosomes in these hepatocytes and changed their exosomal miRNA profile. Moreover, exosomes derived from PA-treated hepatocytes caused an increase in the expression levels of fibrotic genes in HSCs. Therefore, exosomes may have important roles in the crosstalk between hepatocytes and HSCs in the progression from simple steatosis to NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-03389-2

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Palmitic acid treatment increases the production of exosomes in Huh7 and HepG2 cells. (a) CD36 expression levels were measured in Huh7 cells treated with either vehicle or palmitic acid (0.4 mM). (b,c) The total number of exosomes present in the supernatant from vehicle-treated or palmitic-acid treated Huh7 cells (b) and HepG2 cells (c). Data are expressed as the mean ± SEM of three independent experiments. **P < 0.01 compared with the corresponding control.
Figure 1 Palmitic acid treatment increases the production of exosomes in Huh7 and HepG2 cells. (a) CD36 expression levels were measured in Huh7 cells treated with either vehicle or palmitic acid (0.4 mM). (b,c) The total number of exosomes present in the supernatant from vehicle-treated or palmitic-acid treated Huh7 cells (b) and HepG2 cells (c). Data are expressed as the mean ± SEM of three independent experiments. **P < 0.01 compared with the corresponding control.CC BY · PubMed Central
Figure 2 Characterization of exosomes. (a) Expression levels of CD9 (28 kDa) and CD63 (53 kDa) were determined by Western blotting. Protein was extracted from exosomes isolated from Huh7 cultured media. (b) The sizes of isolated exosomes were analyzed using dynamic light scattering. Each analysis was performed 30 times and data are expressed as the mean ± SD. (c) Exosomes visualized by TEM. The scale bar represents 100 nm. (d) The average size of exosomes was measured and data are expressed as the mean ± SD.
Figure 2 Characterization of exosomes. (a) Expression levels of CD9 (28 kDa) and CD63 (53 kDa) were determined by Western blotting. Protein was extracted from exosomes isolated from Huh7 cultured media. (b) The sizes of isolated exosomes were analyzed using dynamic light scattering. Each analysis was performed 30 times and data are expressed as the mean ± SD. (c) Exosomes visualized by TEM. The scale bar represents 100 nm. (d) The average size of exosomes was measured and data are expressed as the mean ± SD.CC BY · PubMed Central
Figure 3 Expression profile of miRNA in exosomes. The heat map shows miRNAs that were significantly changed more than two-fold (P < 0.05) in exosomes from palmitic acid (PA)-treated Huh7 cells compared to exosomes from vehicle-treated Huh7 cells. The left-hand three columns represent the individual miRNA profiles of exosomes from three replicates of vehicle-treated Huh7 cells, whereas the right-hand three columns represent the miRNA profiles of exosomes from three replicates of PA-treated Huh7 cells. The right color bars represent the miRNA expression fold changes; The red color indicates that expression of the miRNA increased in exosomes from the PA-treated group compared to the vehicle-treated group, whereas green indicates that expression of the miRNA decreased in exosomes from the PA-treated group compared to those from the vehicle-treated group.
Figure 3 Expression profile of miRNA in exosomes. The heat map shows miRNAs that were significantly changed more than two-fold (P < 0.05) in exosomes from palmitic acid (PA)-treated Huh7 cells compared to exosomes from vehicle-treated Huh7 cells. The left-hand three columns represent the individual miRNA profiles of exosomes from three replicates of vehicle-treated Huh7 cells, whereas the right-hand three columns represent the miRNA profiles of exosomes from three replicates of PA-treated Huh7 cells. The right color bars represent the miRNA expression fold changes; The red color indicates that expression of the miRNA increased in exosomes from the PA-treated group compared to the vehicle-treated group, whereas green indicates that expression of the miRNA decreased in exosomes from the PA-treated group compared to those from the vehicle-treated group.CC BY · PubMed Central
Figure 4 Volcano plot of miRNA in exosomes. The volcano plot shows the intensity of miRNA expression between exosomes from PA-treated Huh7 cells and exosomes from vehicle-treated Huh7 cells. The horizontal axis represents the log2 ratio and the vertical axis represents −log10 (t-test, P value). The red color indicates that the expression of the miRNA significantly increased more than two-fold in exosomes from the PA-treated group compared to those from the vehicle-treated group. The blue color indicates that the expression of the miRNA significantly decreased more than two fold in exosomes from the PA-treated group compared to those from the vehicle-treated group.
Figure 4 Volcano plot of miRNA in exosomes. The volcano plot shows the intensity of miRNA expression between exosomes from PA-treated Huh7 cells and exosomes from vehicle-treated Huh7 cells. The horizontal axis represents the log2 ratio and the vertical axis represents −log10 (t-test, P value). The red color indicates that the expression of the miRNA significantly increased more than two-fold in exosomes from the PA-treated group compared to those from the vehicle-treated group. The blue color indicates that the expression of the miRNA significantly decreased more than two fold in exosomes from the PA-treated group compared to those from the vehicle-treated group.CC BY · PubMed Central
Figure 5 PA treatment changes expression of miRNA in hepatocytes. (a) The expression profiles of selected miRNAs associated with NASH. (b) The expression levels of miRNA 122 and miRNA 192 were validated using real-time PCR. **P < 0.01 compared with the corresponding control.
Figure 5 PA treatment changes expression of miRNA in hepatocytes. (a) The expression profiles of selected miRNAs associated with NASH. (b) The expression levels of miRNA 122 and miRNA 192 were validated using real-time PCR. **P < 0.01 compared with the corresponding control.CC BY · PubMed Central
Figure 6 Exosomes derived from PA-treated Huh7 cells enhance expression of fibrosis markers in LX2 cells. (a) LX-2 cells were exposed to exosomes isolated from vehicle-treated Huh7 cells or PA-treated (0.4 mM) Huh7 cells. Each isolated exosome was added to the LX-2 cells at a concentration of 50 or 100 μg/mL. The expression levels of α-SMA, TGF-β, and Col1a1 were measured in LX-2 cells using real-time PCR. (b) LX-2 cells were exposed to isolated exosomes (50 μg/ml) from vehicle-treated Huh7 cells or PA-treated Huh7 cells at various concentrations (0.2 mM, 0.4 mM, and 0.8 mM). The expression of α-SMA, TGF-β, and Col1a1 were measured in LX-2 cells using real-time PCR. (c) LX-2 cells were transfected with miRNA 192 or a mimic control. The expression of α-SMA, TGF-β, and Col1a1 was measured in LX-2 cells using real-time PCR. *P < 0.05, **P < 0.01 compared with the corresponding control.
Figure 6 Exosomes derived from PA-treated Huh7 cells enhance expression of fibrosis markers in LX2 cells. (a) LX-2 cells were exposed to exosomes isolated from vehicle-treated Huh7 cells or PA-treated (0.4 mM) Huh7 cells. Each isolated exosome was added to the LX-2 cells at a concentration of 50 or 100 μg/mL. The expression levels of α-SMA, TGF-β, and Col1a1 were measured in LX-2 cells using real-time PCR. (b) LX-2 cells were exposed to isolated exosomes (50 μg/ml) from vehicle-treated Huh7 cells or PA-treated Huh7 cells at various concentrations (0.2 mM, 0.4 mM, and 0.8 mM). The expression of α-SMA, TGF-β, and Col1a1 were measured in LX-2 cells using real-time PCR. (c) LX-2 cells were transfected with miRNA 192 or a mimic control. The expression of α-SMA, TGF-β, and Col1a1 was measured in LX-2 cells using real-time PCR. *P < 0.05, **P < 0.01 compared with the corresponding control.CC BY · PubMed Central
Figure 7 Number of exosomes in the sera in patients with NAFLD and the expression of miRNA 122 and miRNA 192 in exosomes. (a) The total number of exosomes was measured in sera from early stage (n = 3) or advanced stage (n = 3) NAFLD patients. (b) The expression of miRNA 122 and miRNA 192 were analysed using real-time PCR. Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 compared with the corresponding control.
Figure 7 Number of exosomes in the sera in patients with NAFLD and the expression of miRNA 122 and miRNA 192 in exosomes. (a) The total number of exosomes was measured in sera from early stage (n = 3) or advanced stage (n = 3) NAFLD patients. (b) The expression of miRNA 122 and miRNA 192 were analysed using real-time PCR. Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 compared with the corresponding control.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 246

Metadata

Authors
Lee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., Seo, Y. S., Yim, H. J., Jeong, W.-I., Yeon, J. E., Um, S. H., & Byun, K. S.
Affiliations
  • Korea University (KR)
  • Korea Advanced Institute of Science and Technology (KR)
  • Chungnam National University (KR)
Corresponding author
Yeon, Jong Eun
Venue
Scientific Reports
Published
2017-06-16
Volume
7
Issue
1
Pages
3710-3710
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2625576839
Cited by
233
References
44
Citations by year
2026: 6 · 2025: 20 · 2024: 29 · 2023: 33 · 2022: 34 · 2021: 48 · 2020: 35 · 2019: 16 · 2018: 9 · 2017: 3
FWCI
7.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Gilead Sciences
  • National Research Foundation
  • National Research Foundation of Korea (2015R1C1A1A01052360)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
exosomes, palmitic acid, hepatocytes, hepatic stellate cells, liver fibrosis, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, microRNA, CD36
MeSH terms
Animals, Humans, Liver Cirrhosis, Male, Palmitic Acid, Gene Expression Profiling, Hepatocytes, MicroRNAs, Cell Line, Tumor, Mice, Hepatic Stellate Cells, Exosomes, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. https://app.cochat.ai/papers/10.1038/s41598-017-03389-2
The paper
Lee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., Seo, Y. S., Yim, H. J., Jeong, W.-I., Yeon, J. E., Um, S. H., & Byun, K. S. (2017). Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Scientific Reports. https://doi.org/10.1038/s41598-017-03389-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.